Institute of Pharmacovigilance
← Career Framework
ScientificS.I.RM.RMS

Risk Management Scientist

Scientific · Industry · Risk Management

Performs safety analyses and contributes to development and maintenance of RMPs/REMS.

Also known as: PV and Risk Management Scientist

Draft

This competency standard is a working draft prepared for reviewand is not yet an official GPPC standard. Content is derived from the role’s job description and established pharmacovigilance practice, and is subject to change.

Job description

  • Perform and contribute to safety analyses through review of case series, tabulated data and/or adverse event trend information.
  • Contribute to document authoring, describing the evaluated safety data and assigned product(s).
  • Perform and contribute with more senior scientists and safety physicians to signal detection activities and the signal management process.
  • Collaborate with more senior scientists and safety physicians on risk management activities.
  • Participate in the development and maintenance of RMPs/REMS.
  • Participate in the review of medical/scientific literature to identify the literature relevant for signal detection activities and aggregate reporting.
  • Participate in the preparation of aggregate safety reports.
  • Contribute to the creation and maintenance of the RSI and company core labelling.
  • Contribute, participate, and support Benefit-Risk Team meetings, including materials preparation, meeting minutes, and action item tracking.
  • Contribute to a regulatory authority or other safety-related query responses.
  • Participate in continuous process improvement projects and proactively identify and resolve issues related to safety risk management.
  • Ensure that risk management documents are compliant with relevant regulatory requirements.
  • Participate in inspection/audit related readiness activities and provide support for internal and external PV audits.
  • Develop and deliver relevant training.

Overall required level: Intermediate.Draft competency standard for the Risk Management Scientist role. As a scientific role, intermediate-to-expert command of the relevant scientific domain and its regulatory context is expected. Levels are an initial proposal derived from the role's job description and typical pharmacovigilance practice, pending expert review.

Prerequisites

Mandatory prerequisites

  • University degree in medicine, pharmacy, life sciences or a related discipline
  • Relevant pharmacovigilance experience appropriate to the role

Recommendations

  • Working proficiency in English
  • Familiarity with the applicable GVP modules

Concept of levels

Knowledge for each topic is assessed on a four-level scale.

LevelExpected knowledge
N/ANo knowledge required.
BasicElementary knowledge of the specific regulation; fundamental understanding of the terms and definitions used, a basic understanding of the concept of the regulation, a general overview of what it covers and where it can be found; passive/delegated usage of the regulation.
IntermediateVery good knowledge of the specific regulation; comprehensive understanding of the terms and definitions and of the concept and context of who/when/where/why/how it applies; active usage of the regulation when required.
ExpertExcellent knowledge of the specific regulation; in-depth understanding of the concept and of how and why its sections should be implemented and followed, including outcomes and responsibilities for all relevant stakeholders; active usage of the regulation on a daily basis.

Knowledge

General Knowledge

TopicLevel
Pharmacovigilance principles and Good Pharmacovigilance Practices (GVP) overviewRef: EMA GVP Module I — Pharmacovigilance systems and their quality systems; EU Reg (EC) 726/2004 & Dir 2001/83/ECIntermediate
The pharmacovigilance system and Pharmacovigilance System Master File (PSMF)Ref: EMA GVP Module II — Pharmacovigilance system master file (Rev 2)Intermediate
Individual case safety report (ICSR) management and regulatory reporting timelinesRef: EMA GVP Module VI (Rev 2); ICH E2D(R1); ICH E2B(R3)Intermediate

Role-Specific Knowledge

Includes topics derived from this role's job description.

TopicLevel
Risk management planning (GVP Module V): RMP structure and lifecycleRef: EMA GVP Module V — Risk management systems (Rev 2)Expert
Risk minimisation measures and REMSRef: EMA GVP Module XVI — Risk minimisation measures (Rev 3)Expert
Benefit–risk assessment methodologyRef: ICH E2C(R2) — Periodic Benefit-Risk Evaluation Report (PBRER)Intermediate
Post-authorisation safety studies (PASS/PAES)Ref: EMA GVP Module VIII — Post-authorisation safety studies (Rev 3)Intermediate
Signal management process (GVP Module IX)Ref: EMA GVP Module IX — Signal management (Rev 1)Intermediate
Aggregate safety reports (PBRER/PSUR, DSUR)Ref: EMA GVP Module VII (PSUR); ICH E2C(R2) (PBRER); ICH E2F (DSUR)Intermediate
Audits and regulatory inspectionsRef: EMA GVP Module IV — Pharmacovigilance audits (Rev 1); GVP Module III — Pharmacovigilance inspectionsIntermediate
Literature monitoring and reviewRef: EMA GVP Module VI (Rev 2) — literature monitoringBasic
Training, education and capacity buildingRef: WHO Pharmacovigilance Core Curriculum for University TeachingBasic

Knowledge · Skills · Attitude

A summary of the competency elements expected for this role.

ElementKnowledgeSkillsAttitude
Risk planning
  • RMP/REMS structure
  • Contributing to risk management plans
  • Patient-centred risk mindset
Risk minimisation
  • Routine and additional RMMs
  • Designing and assessing minimisation measures
  • Proportionality
Benefit–risk
  • B/R methodology
  • Synthesising safety data into B/R conclusions
  • Balanced judgement

Get certified for this role

Certification validates prerequisites via CV screening and assesses knowledge through an online, AI-proctored examination based on the competency standard. The latest terms and requirements for every role and region are maintained by the Institute of Pharmacovigilance.

iVigee

Pharmacovigilance Regulatory Intelligence Partner

Training Partners

Pharmacovigilance Education & Congresses